Ibrutinib- and bortezomib-extended R-CHOP induction in elderly higher-risk patients newly diagnosed with diffuse large B-cell lymphoma – first analysis of toxicity and efficacy signals
暂无分享,去创建一个
C. Schmitt | L. Bullinger | J. Dürig | A. Hüttmann | C. Bogner | C. Trenker | J. Kase | R. Marks | M. Janz | S. Mathas | U. Keller | Sophy Denker | Il-Kang Na | M. Frick | Aitomi Bittner | J. Hoffmann | Ulrike Krohn | A. Bittner | Mareike Frick